Articles From: Cytori Consolidates European Operations to Newly Opened Welsh Manufacturing Facility to Sophiris Bio Reports Completion of Enrollment in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia


Cytori Therapeutics (NASDAQ: CYTX) has consolidated its EU operations to a new European office combined with a manufacturing facility in Deeside, Wales, UK.
Sign-up for Cytori Consolidates European Operations to Newly Opened Welsh Manufacturing Facility investment picks
- $4.5 billion-$5 billion pipeline would bring 1.5 billion cubic feet of natural gas per day to North Carolina and Virginia - 'Transformational' project provides growing Mid-Atlantic markets a new route for access to competitive, domestic energy supplies - Investment would create thousands of jobs, promote economic development and cleaner air, increase state and local tax revenue - Pipeline expected to be in service by late 2018, pending regulatory approvals RICHMOND, Va.
Sign-up for Dominion, Duke Energy, Piedmont Natural Gas and AGL Resources Form Joint Venture to Own Proposed Atlantic Coast Pipeline investment picks
BEDFORD, Mass.
Sign-up for Hologic to Present at the Morgan Stanley Global Healthcare Conference investment picks
LRR Energy, L.P. (NYSE:LRE) (“LRR Energy”) announced today that it has signed a definitive agreement to acquire oil and natural gas properties in Lincoln and Creek Counties, Oklahoma for a purchase price of $38.0 million, subject to customary purchase price adjustments.
Sign-up for LRR Energy, L.P. to Acquire Oil and Gas Producing Properties in Oklahoma investment picks
--National Home Prices Are Expected to Rise 5.7 Percent from July 2014 to July 2015--
Sign-up for CoreLogic Reports Home Prices Rose By 7.4 Percent Year Over Year In July investment picks
PLAINSBORO, N.J., Sept.
Sign-up for Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business investment picks
SOUTH SAN FRANCISCO, Calif., Sept.
Sign-up for Portola Pharmaceuticals to Present at the 2014 Morgan Stanley Global Healthcare Conference investment picks
WageWorks, Inc. (NYSE: WAGE), a leader in administering Consumer-Directed Benefits, today announced that Colm Callan has been appointed the Company’s Chief Financial Officer (CFO), effective immediately.
Sign-up for WageWorks Appoints Colm Callan as Chief Financial Officer investment picks
MONTVALE, N.J. , Sept.
Sign-up for AEP Industries Inc. Schedules Conference Call To Discuss Third Quarter 2014 Financial Results investment picks
Ultra-broadband 100G technology will address ever-growing demand for network capacity in Spain fueled by increased use of video and cloud services PARIS , Sept.
Sign-up for Alcatel-Lucent to develop 100G optical network for Telefonica Spain investment picks
Altera Recognized by Fuji Xerox for Second Consecutive Year for Meeting Rigorous Quality, Cost and Delivery Standards SAN JOSE, Calif.
Sign-up for Fuji Xerox Recognizes Altera with 2014 Premier Partner Award investment picks
Brookdale Senior Living (NYSE:BKD) and HCP (NYSE:HCP) today announced the closing of their previously disclosed multiple-element transaction, including: i) the creation of a $1.2 billion strategic joint venture initially owning a portfolio of 14 entry fee CCRCs, and ii) amendments to the triple-net leases on 202 HCP-owned senior housing communities formerly operated by Emeritus Corporation, which was acquired by Brookdale in July 2014.
Sign-up for Brookdale and HCP Complete Previously Disclosed Creation of $1.2 Billion CCRC Joint Venture and Amendment of Former Emeritus Leases investment picks
Novatel Wireless, Inc. (NASDAQ: NVTL), a leading provider of Internet of Things, announced that the Company has appointed Michael Newman as Executive Vice President and Chief Financial Officer.
Sign-up for Novatel Wireless Appoints Chief Financial Officer investment picks
SEATTLE , Sept.
Sign-up for Oncothyreon to Present at Rodman & Renshaw Global Investment Conference investment picks
Vitesse Semiconductor Corporation (Nasdaq: VTSS), a leading provider of advanced IC solutions for Carrier , Enterprise and Internet of Things ( IoT ) networks, announced that Vubiq Networks is using Vitesse’s CEServices™ software , Serval-Lite™ VSC7416 Carrier Ethernet switch engine, and VSC8574 Gigabit Ethernet PHY for Vubiq Networks’ latest generation 60GHz millimeter wave wireless system targeted at wireless fiber extension and 4G / LTE backhaul applications.
Sign-up for Vubiq Networks Selects Vitesse for Wireless Broadband Platform investment picks
MARLBOROUGH, Mass.
Sign-up for Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG investment picks
LYNBROOK, N.Y. , Sept.
Sign-up for BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences investment picks
SFX Entertainment, Inc. (NASDAQ:SFXE) (“SFX”) announced today that it has extended the expiration date of its previously announced consent solicitation (the “Solicitation”) to a proposed amendment (the “Proposed Amendment”) to the indenture (the “Indenture”) governing its outstanding 9.625% Second Lien Senior Secured Notes due 2019 (the "Securities"). The Solicitation will now expire at 5:00 p.m., New York City time, on September 5, 2014, unless further extended (as extended, the “Expiration Time”). The full terms of the Solicitation are detailed in SFX’s consent solicitation statement (the “Statement”) and related consent form, each dated as of August 19, 2014.
Sign-up for SFX Entertainment, Inc. Announces Extension of Consent Solicitation Relating to Its 9.625% Second Lien Senior Secured Notes Due 2019 investment picks
DUBLIN , Sept.
Sign-up for FLY Leasing Acquires Two Airbus A330-300 Aircraft investment picks
Kyungpook National University Hospital in South Korea Treats the First Patient in the 14 Country, 100 Site Global Study Study Designed to Support Registration in Major Liver Cancer Markets Worldwide LAWRENCEVILLE, N.J. , Sept.
Sign-up for Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer investment picks
VICTORIA, B.C., Sept.
Sign-up for Aurinia Pharmaceuticals to Begin Trading on the NASDAQ Global Market investment picks
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing PRX302 (topsalysin) for the treatment of the symptoms of benign prostatic hyperplasia (BPH, enlarged prostate) and for the treatment of localized prostate cancer, today announced that it has fully enrolled its ongoing Phase 3 trial (referred to as PLUS-1) of PRX302 as a treatment for lower urinary tract symptoms of BPH.
Sign-up for Sophiris Bio Reports Completion of Enrollment in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Cytori Consolidates European Operations to Newly Opened Welsh Manufacturing Facility to Sophiris Bio Reports Completion of Enrollment in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices